These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7013141)

  • 41. Endocrine arterial hypertension: therapeutic approach in clinical practice.
    Mazza A; Armigliato M; Zamboni S; Rempelou P; Rubello D; Pessina AC; Casiglia E
    Minerva Endocrinol; 2008 Dec; 33(4):297-312. PubMed ID: 18923367
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The adrenergic regulation of the cardiovascular system in the South American rattlesnake, Crotalus durissus.
    Galli GL; Skovgaard N; Abe AS; Taylor EW; Wang T
    Comp Biochem Physiol A Mol Integr Physiol; 2007 Nov; 148(3):510-20. PubMed ID: 17669676
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients.
    Paran E; Anson O; Neumann L
    Am J Hypertens; 1996 Dec; 9(12 Pt 1):1206-13. PubMed ID: 8972892
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alpha and beta adrenergic blockade in hypertension.
    Beilin LJ; Juel-Jensen BE
    Lancet; 1972 May; 1(7758):979-82. PubMed ID: 4112366
    [No Abstract]   [Full Text] [Related]  

  • 45. Chronic adrenergic receptor blockade does not prevent hyperinsulinemia-induced hypertension in rats.
    Keen HL; Brands MW; Alonso-Galicia M; Hall JE
    Am J Hypertens; 1996 Dec; 9(12 Pt 1):1192-9. PubMed ID: 8972890
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effect of phentolamine on portal pressure in cirrhotic patients with portal hypertension].
    Zhu J; Leng X; Yin J
    Zhonghua Wai Ke Za Zhi; 1997 Feb; 35(2):92-4. PubMed ID: 10374485
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
    Wiśniewska RJ
    Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
    [TBL] [Abstract][Full Text] [Related]  

  • 48. beta1-Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension.
    Liu J; Liu ZQ; Yu BN; Xu FH; Mo W; Zhou G; Liu YZ; Li Q; Zhou HH
    Clin Pharmacol Ther; 2006 Jul; 80(1):23-32. PubMed ID: 16815314
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Results with new beta receptor blockaders in the therapy of glaucoma].
    Merkle W
    Fortschr Ophthalmol; 1983; 79(5):413-4. PubMed ID: 6135652
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effectiveness of antihypertensive treatment with labetalol as compared with the combination of hydralazine and propranolol].
    Fea F; Salvioli G; Planca E; Pelliccioli I; Foti F; Colombo G
    Boll Soc Ital Cardiol; 1981; 26(12):2173-82. PubMed ID: 7185386
    [No Abstract]   [Full Text] [Related]  

  • 51. [Phase IV study of an adrenergic beta-blocker].
    Duchéne-Marullaz P
    Therapie; 1983; 38(4):363-70. PubMed ID: 6359565
    [No Abstract]   [Full Text] [Related]  

  • 52. Methyldopa and propranolol in moderate hypertension.
    Agarwal RK; Bhatnagar MK; Shukla SK; Gupta R; Dwivedi RN
    Indian Heart J; 1980; 32(1):13-5. PubMed ID: 7380450
    [No Abstract]   [Full Text] [Related]  

  • 53. [Plasma dopamine beta-hydroxylase activity in hypertension treated with adrenergic beta receptor blockaders].
    Merkulova NK
    Ter Arkh; 1981; 53(1):69-72. PubMed ID: 7221913
    [No Abstract]   [Full Text] [Related]  

  • 54. [Chronotropic effect of a combined injection of calcium ions and beta-receptor blockaders].
    Teichmann W; Schäbitz J; Lukesch KH; Schmidt GA; Rikirsch P
    Z Gesamte Inn Med; 1971 Mar; 26(6):205-7. PubMed ID: 4397851
    [No Abstract]   [Full Text] [Related]  

  • 55. [Treatment of hypertension in the year 2000: do we all agree?].
    Navazio F
    Clin Ter; 2000; 151(4):253-5. PubMed ID: 11107674
    [No Abstract]   [Full Text] [Related]  

  • 56. [Use of adrenergic beta receptor blockaders in myocardial infarct].
    Florkiewicz H; Rymar B; Przegaliński J; Markiewicz M
    Pol Tyg Lek; 1980 Jun; 35(23):853-5. PubMed ID: 6997844
    [No Abstract]   [Full Text] [Related]  

  • 57. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
    Itskovitz HD
    Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Value of combination therapy in treatment of hypertension].
    Kreutz R
    Krankenpfl J; 2005; 43(7-10):255. PubMed ID: 16515324
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension.
    Sasaki J; Kajiyama G; Kusukawa R; Mori H; Koga S; Takagi R; Tanaka N; Ogawa N; Arakawa K
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):660-4. PubMed ID: 7881705
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical evaluation of bevantolol hydrochloride in patients with severe hypertension. The Cooperative Study Group on Bevantolol in Japan.
    Noshiro T; Miura Y; Yoshinaga K; Iimura O; Inagaki Y; Saruta T; Ishii M; Yamazaki N; Arakawa K
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):240-5. PubMed ID: 7620695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.